InsiderTrades

Form 4 for WGS GeneDx Holdings Corp.

Accepted 2024-10-31 00:00:00 ET · period of report 2024-10-29 · accession 0001415889-24-025838 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-10-31 2024-10-29 WGS Feeley Kevin CFO M - OptEx $0.00 +753 45.2K +2% $0
D 2024-10-31 2024-10-29 WGS Feeley Kevin CFO S - Sale+OE $66.60 -274 45.0K -0.6% -$18.2K
D 2024-10-31 2024-10-29 WGS Feeley Kevin CFO M - OptEx $0.00 -753 4,520 -14% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2024-10-29 M A 753 $0.00 45,225 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
2 Common Class A Common Stock 2024-10-29 S D 274 $66.60 44,951 D — —
3 Derivative Restricted Stock Unit 2024-10-29 M D 753 $0.00 4,520 D — · — to — 753 Class A Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F3) 25% of the underlying shares each vested on April 29, 2023 and April 29, 2024, and 6.25% vest in quarterly installments thereafter until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.